What We Do

Our mission includes finding answers for some of the world's most urgent medical needs. We focus our internal research efforts primarily on four core therapeutic areas: bio-medicines, diabetes, oncology and animal health. We also continue to pursue innovative science and new opportunities beyond our targeted disease categories.
 

Lilly Bio-Medicines
(autoimmunity, cardiovascular, musculoskeletal, neuroscience & urology)
 

Lilly Bio-Medicines comprises the largest of Lilly’s five business areas in terms of sales, and accounts for nearly half of Lilly’s mid-to-late stage pipeline assets. 

   

Lilly Diabetes

Lilly Diabetes remains committed to meeting the needs of people with diabetes; from medicines to support programmes, including investing in one of our largest diabetes pipelines ever.

   

Lilly Oncology

As one of the top 10 oncology companies in the world, Lilly Oncology focuses on speeding innovation and improving outcomes for individual patients, and boasts one of the largest clinical pipelines in the oncology industry. 

   

Elanco Animal Health

A global division of Lilly, Elanco works to develop and market products that improve animal health and protein production in more than 75 countries across the globe.

   

  Lilly R&D

Lilly Research Laboratories (LRL) discovers and develops high- quality innovative medicines that help patients live longer, healthier, happier lives.